{"id":5353,"date":"2024-12-07T13:13:20","date_gmt":"2024-12-07T07:43:20","guid":{"rendered":"https:\/\/lakshmishree.com\/news\/?p=5353"},"modified":"2024-12-07T13:13:22","modified_gmt":"2024-12-07T07:43:22","slug":"suven-pharma-acquires-majority-stake-in-us-based-nj-bio-for-64-4-million","status":"publish","type":"post","link":"https:\/\/lakshmishree.com\/news\/suven-pharma-acquires-majority-stake-in-us-based-nj-bio-for-64-4-million\/","title":{"rendered":"Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million"},"content":{"rendered":"\n<p>Hyderabad-based Suven Pharmaceuticals has entered into definitive agreements to acquire a 56% equity stake in NJ Bio, Inc., a Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Princeton, New Jersey. The $64.4 million transaction comprises a mix of primary equity infusion and secondary share acquisition.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Key Details of the Acquisition<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Primary Investment<\/strong>: Suven will invest $15 million in primary equity to support NJ Bio&#8217;s growth initiatives.<\/li>\n\n\n\n<li><strong>Secondary Acquisition<\/strong>: The deal involves buying 9.3 lakh common equity shares from existing shareholders and subscribing to 2.8 lakh newly issued shares.<\/li>\n\n\n\n<li><strong>Future Ownership Options<\/strong>: Suven has secured call and put options to acquire the remaining shares after five years, potentially taking its stake to 100%.<\/li>\n<\/ul>\n\n\n\n<p>NJ Bio is a company that specializes in next-generation drug conjugates such as antibody-drug conjugates and other targeted therapies, thus positioning Suven to scale up its biopharma innovation footprint further.<\/p>\n\n\n\n<p>Post-acquisition, NJ Bio would be a subsidiary of Suven Pharma, and its Indian arm, NJBIO India Pharmaceutical Private Limited, and US-based NJ Biotherapeutics, LLC, would be classified as step-down subsidiaries.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Suven Pharma\u2019s Performance and Market Reaction<\/h3>\n\n\n\n<p>In Q2 FY25, Suven Pharma recorded:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Net Sales<\/strong>: \u20b9236.1 crore, a 5% year-on-year increase.<\/li>\n\n\n\n<li><strong>Net Profit<\/strong>: \u20b976.3 crore, up by 2.2% from \u20b974.7 crore last year.<\/li>\n<\/ul>\n\n\n\n<p>Despite the acquisition news, Suven Pharma\u2019s stock closed 0.4% lower on December 6 at \u20b91,291.45.<\/p>\n\n\n\n<p>This strategic acquisition aligns with Suven&#8217;s goal of strengthening its position in the global pharmaceutical sector, particularly in advanced drug research and development.<\/p>\n\n\n\n<p>Do you have a news tip for Lakshmishree reporters? Please email us at <a>media@lakshmishree.com<\/a><\/p>\n\n\n\n<p><em><sup><sub>Source: <a href=\"https:\/\/www.moneycontrol.com\/news\/business\/markets\/suven-pharma-acquires-majority-stake-in-us-based-nj-bio-12885182.html\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/www.moneycontrol.com\/news\/business\/markets\/suven-pharma-acquires-majority-stake-in-us-based-nj-bio-12885182.html\" rel=\"noreferrer noopener nofollow\">Moneycontrol<\/a><\/sub><\/sup><\/em><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hyderabad-based Suven Pharmaceuticals has entered into definitive agreements to acquire a 56% equity stake in NJ Bio, Inc., a Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Princeton, New Jersey. The $64.4 million transaction comprises a mix of primary equity infusion and secondary share acquisition. Key Details of the Acquisition NJ Bio is a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5354,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[50],"tags":[776],"class_list":["post-5353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-indian-market","tag-suven-pharma"],"_links":{"self":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/5353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/comments?post=5353"}],"version-history":[{"count":1,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/5353\/revisions"}],"predecessor-version":[{"id":5355,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/5353\/revisions\/5355"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/media\/5354"}],"wp:attachment":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/media?parent=5353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/categories?post=5353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/tags?post=5353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}